N01 Type of patient education impacts the willingness to switch from an IV to SC of a biological in patients with Inflammatory Bowel Disease: A multicentre, comparative study

Autor: E De Dycker, E Hoefkens, K Asnong, P Geens, N Lembrechts, T Lambrechts, I Van de Schoot, A Paps, S Vermeire, L Pouillon, M Ferrante, P Bossuyt

Publikováno v: Journal of Crohn's and Colitis. 16:i617-i618

Background Subcutaneous (SC) formulations of CT-P13 and vedolizumab (VED) are currently available as new treatment option for patients with inflammatory bowel disease (IBD). The decision to switch requires a shared decision making based on adequate e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::482e36675a03a95d4036d69ce5429711
https://doi.org/10.1093/ecco-jcc/jjab232.863

High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial

Autor: Jessica R. de Bruyn, Peter Bossuyt, Marc Ferrante, Rachel L. West, Gerard Dijkstra, Ben J. Witteman, Manon Wildenberg, Frank Hoentjen, Denis Franchimont, Esmé Clasquin, Jarmila D. van der Bilt, Tim Tollens, Willem A. Bemelman, Andre D’Hoore, Marjolijn Duijvestein, Geert R. D’Haens, W. Bemelman, C. Buskens, E. Clasquin, J. De Bruyn, G. D’Haens, M. Duijvestein, J. Van der Bilt, B. Ferreira, S. Mulder, R. West, G. Dijkstra, A. Engelsman, J. Lange, L. Homans, B. Witteman, A. Eroglu-Berger, M. Russel, J. Jansen, T. Schakel–van den Berge, S. Cuppen, F. Hoentjen, A. Van Esch, D.J. De Jong, N. Mahmmod, W. Ten Hove.P. De Lange, R. Mallant, P. Houben, M. Ferrante, S. Vermeire, A. Outtier, T. Hermans, J. Lefrère, A. D’Hoore, K. Asnong, P. Bossuyt, I. Van de Schoot, B. Claerbout, G. Lambrecht, L. Boutaffala, C. Guebelle, E. Louis, D. Franchimont, V. Wambacq, A. Colard, A. Deflandre

Publikováno v: Clinical Gastroenterology and Hepatology, 19, 1573-1582.e5
Clinical Gastroenterology and Hepatology, 19, 8, pp. 1573-1582.e5
Clinical Gastroenterology and Hepatology, 19(8), 1573-1582.e5. ELSEVIER SCIENCE INC
Clinical gastroenterology and hepatology, 19(8), 1573-1582.e5. W.B. Saunders Ltd

BACKGROUND & AIMS: Vitamin D deficiency is common in Crohn's disease (CD). High-dose vitamin D had anti-inflammatory effects in preclinical studies and trials of patients with CD. We performed a randomized trial to determine whether high-dose vitamin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745c4b94532c3a697791ed92464ebe3c
https://hdl.handle.net/2066/237041